Physician
Hanissian, Talynn
Hanissian, Talynn was paid $2.34M by Medicaid between Oct 2019 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoHANISSIAN, TALYNN
HOUSTON, TX 77075
HOUSTON, TX 77075
33aNPI1891749339assigned 05/20/2006
33bProvider typePediatrics Physician
28Total paid$2.34M
24GClaims141,149
24DCodes billed91
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#205 of 1,136
Median peer was paid$329K
This provider vs. median7.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,605 | $16K | |
| 2020 | 21,195 | $334K | |
| 2021 | 36,204 | $553K | |
| 2022 | 33,540 | $535K | |
| 2023 | 33,200 | $568K | |
| 2024incomplete | 15,405 | $338K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 22,283 | 17,308 | $886K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 1,838 | 1,806 | $166K |
| 99000 | 6.9% | 14,577 | 12,584 | $163K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.9% | 1,646 | 1,598 | $162K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.2% | 2,549 | 2,326 | $144K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 1,467 | 1,429 | $125K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.9% | 10,869 | 5,140 | $115K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.5% | 1,835 | 1,770 | $83K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 2,148 | 2,038 | $59K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.3% | 653 | 638 | $54K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 3,585 | 3,426 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 7,307 | 6,788 | $48K |
79 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 3,733 | $31K |
| 80061 | Lipid panel | 1.3% | 3,138 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,151 | $30K |
| 97802 | <1% | 5,156 | $22K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,570 | $22K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,373 | $20K |
| 99429 | <1% | 631 | $17K | |
| 83655 | <1% | 1,304 | $14K | |
| 92552 | <1% | 4,254 | $10K | |
| 81000 | <1% | 2,264 | $8K | |
| 99241 | <1% | 904 | $8K | |
| 90461 | <1% | 1,106 | $7K | |
| 82652 | <1% | 881 | $6K | |
| 87807 | <1% | 452 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,712 | $5K |
| 99242 | <1% | 59 | $4K | |
| 99050 | <1% | 323 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 42 | $4K |
| 0071A | <1% | 104 | $4K | |
| 0002A | <1% | 90 | $4K | |
| 0072A | <1% | 96 | $4K | |
| 0001A | <1% | 80 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,307 | $3K |
| S9441 | Asthma education, non-physician provider, per session | <1% | 145 | $3K |
| 86328 | <1% | 68 | $2K | |
| 82947 | <1% | 1,281 | $2K | |
| 87081 | <1% | 2,915 | $2K | |
| 84439 | <1% | 1,366 | $2K | |
| 80050 | General health panel | <1% | 45 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 2,204 | $1K |
| 36410 | <1% | 95 | $1K | |
| 96160 | <1% | 477 | $1K | |
| 69210 | <1% | 26 | $863.13 | |
| 98960 | <1% | 45 | $568.10 | |
| 0003A | <1% | 12 | $524.00 | |
| 87088 | <1% | 568 | $174.20 | |
| 36416 | <1% | 4,559 | $169.89 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 65 | $158.00 |
| 90686 | <1% | 2,075 | $157.98 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | $149.71 |
| 90756 | <1% | 44 | $86.35 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 544 | $53.39 |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,320 | $40.45 |
| 99401 | <1% | 1,494 | $24.26 | |
| 94760 | <1% | 122 | $9.40 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 189 | $1.86 |
| 90620 | <1% | 358 | $0.52 | |
| 90734 | <1% | 287 | $0.10 | |
| 90651 | <1% | 318 | $0.06 | |
| 90715 | <1% | 127 | $0.04 | |
| 90619 | <1% | 198 | $0.01 | |
| 90670 | 0% | 628 | $0.00 | |
| 90671 | 0% | 136 | $0.00 | |
| 90707 | 0% | 301 | $0.00 | |
| 99173 | 0% | 3,790 | $0.00 | |
| 90633 | 0% | 332 | $0.00 | |
| 90649 | 0% | 485 | $0.00 | |
| 91300 | 0% | 271 | $0.00 | |
| 90672 | 0% | 29 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 89 | $0.00 |
| 90700 | 0% | 14 | $0.00 | |
| 80076 | 0% | 14 | $0.00 | |
| 90685 | 0% | 37 | $0.00 | |
| 1031F | 0% | 2,243 | $0.00 | |
| 90716 | 0% | 311 | $0.00 | |
| 90647 | 0% | 384 | $0.00 | |
| 90696 | 0% | 33 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 2,776 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 468 | $0.00 |
| 82962 | 0% | 1,608 | $0.00 | |
| 96127 | 0% | 101 | $0.00 | |
| 90680 | 0% | 265 | $0.00 | |
| 91307 | 0% | 222 | $0.00 | |
| 90723 | 0% | 36 | $0.00 | |
| 84436 | 0% | 18 | $0.00 | |
| 90697 | 0% | 25 | $0.00 | |
| 1005F | 0% | 28 | $0.00 | |
| 90677 | 0% | 13 | $0.00 | |
| 96161 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.